Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tal Marshanski, Eliana Fanous, Noa Tal, Tsachi T. Perets, Manar Matar, Yael Weintraub, Raanan Shamir, Dror S. Shouval
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Pediatric Gastroenterology and Nutrition
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items